ADMA Biologics, Inc.
S&P 600
$9.23
-1.70%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.18.
- Comfortable interest cover: operating profit covers interest about 26.9 times.
- Return on equity is healthy at 36%.
- Return on capital employed is healthy at 31.2%.
- Net profit margin is strong at 28.8%.
- Current assets comfortably cover current liabilities (current ratio 6.71).
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
11.46
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
5 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$2.07B
Current Price$ 9.23
High / Low$ 20.46 / 7.21
Stock P/E13.185714
Book Value$ 1.77
Dividend Yield0%
ROCE31.15%
ROE35.99%
Debt to Equity0.18
Current Ratio6.71
P/B Ratio5.0966315
EPS$ 0.60
Debt$72.14M
PAT Margin28.80%
Cash PAT$154.93M
ICR26.93